Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2025-12-25 @ 4:16 AM
NCT ID:
NCT00002720
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven stage I, invasive breast cancer
* Hormone receptor status:
* Estrogen receptor positive
* Progesterone receptor positive or negative
PATIENT CHARACTERISTICS:
Age:
* 65 to 80
Sex:
* Female
Menopausal status:
* Postmenopausal
Performance status:
* Not specified
Life Expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No serious disease that would preclude surgery
* No other prior or concurrent malignancy except basal cell carcinoma or carcinoma in situ of the cervix
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
65 Years
Maximum Age:
80 Years
Study:
NCT00002720
Study Brief:
Protocol Section:
NCT00002720